| Literature DB >> 33199085 |
Shiying Shao1, Ruping Pan2, Yong Chen3.
Abstract
Application of autologous platelet-rich plasma (PRP), especially leukocyte- and platelet-rich fibrin (L-PRF), has emerged as a promising adjuvant therapy for the treatment of diabetic foot ulcers (DFUs). Conflicting results of PRP efficacy can be attributed to the lack of standardization in the PRP preparation process in addition to a paucity of well-designed randomized clinic trials (RCTs).Entities:
Keywords: diabetic foot ulcer; leukocyte- and platelet-rich fibrin; platelet-rich plasma; type 2 diabetes mellitus
Year: 2020 PMID： 33199085 DOI： 10.1016/j.tem.2020.10.003
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN： 1043-2760 Impact factor: 12.015